Raynovent Announces Approval of Category 1 Drug ZSP0678 for Clinical Trials of NASH Indication Time:2019.04.11Views:85Author:众生睿创 Previous:Raynovent Announces Acceptance of IND Application of a Category 1 Drug, ZSP0678 for NASH Indication. Next:No articles News Center
